Junzo P. Chino

Junzo P. Chino

Radiation Oncology

20 Duke Medicine Cir
Durham, NC 27710

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 13, 2026

Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: February 11, 2026

Fear and Medical Misinformation Regarding Risk of Progression or Recurrence Among Patients with Breast Cancer.

Fear and Medical Misinformation Regarding Risk of Progression or Recurrence Among Patients with Breast Cancer.

Journal: JAMA network open

Published: February 03, 2026

Molecular Classification Refines Adjuvant Radiation Therapy Use in Stage III Endometrial Cancer Exhibiting No Specific Molecular Profile.

Molecular Classification Refines Adjuvant Radiation Therapy Use in Stage III Endometrial Cancer Exhibiting No Specific Molecular Profile.

Journal: Practical radiation oncology

Published: January 28, 2026

Radiation Quality and Workflow in NRG GY017: Anti-PD-L1 (Atezolizumab) as an Immune Primer or Concurrently With Radiation Therapy for Node-Positive Locally Advanced Cervical Cancer.

Radiation Quality and Workflow in NRG GY017: Anti-PD-L1 (Atezolizumab) as an Immune Primer or Concurrently With Radiation Therapy for Node-Positive Locally Advanced Cervical Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: January 12, 2026

Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer.

Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer.

Journal: International journal of radiation oncology, biology, physics

Published: January 12, 2026

Design and Implementation of Novel Internal Mini Fellowship Concentrations Within a Radiation Oncology Residency Program.

Design and Implementation of Novel Internal Mini Fellowship Concentrations Within a Radiation Oncology Residency Program.

Journal: International journal of radiation oncology, biology, physics

Published: November 04, 2025

Rapid AI Auto-Planning Rivals Manual Expert Planning for Cervical Brachytherapy.

Rapid AI Auto-Planning Rivals Manual Expert Planning for Cervical Brachytherapy.

Journal: Practical radiation oncology

Published: October 24, 2025

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: August 05, 2025

Health equity, disparities, and barriers to cervical cancer care in the U.S.: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS addressing the WHO cervical Cancer elimination campaign goals related to treatment.

Health equity, disparities, and barriers to cervical cancer care in the U.S.: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS addressing the WHO cervical Cancer elimination campaign goals related to treatment.

Journal: Gynecologic oncology

Published: July 14, 2025

Minimum standards for radiation therapy in the treatment of cervical cancer in the U.S.: A consensus statement by SGO, ASTRO, and ABS addressing the WHO Cervical Cancer Elimination Campaign goals.

Minimum standards for radiation therapy in the treatment of cervical cancer in the U.S.: A consensus statement by SGO, ASTRO, and ABS addressing the WHO Cervical Cancer Elimination Campaign goals.

Journal: Gynecologic oncology

Published: July 11, 2025

Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.S.

Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.S.

Journal: Gynecologic oncology

Published: July 08, 2025

Showing 1-12 of 139

Last Updated: 09/26/2026